The combination of HOTTIP, PVT1, and UCA1 is identified to be a clinical predictive panel to differentiate CRC patients with lymph node metastasis from CRC patients with non-metastatic lymph nodes and healthy people [308]. Here, UCA1 is linked to metastatic malignant neoplasm in the lymph nodes.